Developer docs
API playgroundTry for free, no card

Search company profiles

Dosch Pharmaceuticals

Full company profile

uuid0021516

Namestring
Dosch Pharmaceuticals
Legal namestring
Dosch Pharmaceuticals Pvt. Ltd.
Websiteurl
dosch.com
Company typeenum
Private
Founded yearint
1990
Descriptiontext

Dosch Pharmaceuticals Pvt. Ltd. is a Mumbai-based, privately held B2B pharmaceutical services company that operates as an integrated enablement platform for pharmaceutical manufacturers in Central Africa. Established approximately three decades ago, the company qualifies and sources APIs, excipients, packaging materials, and finished goods from India, China, and Europe to WHO Prequalification standards, then delivers them via air and sea freight into the Central African corridor at a rate of more than 1,000 container shipments annually, completing the route with door-to-plant final-mile logistics.

The company's offering is structured around six interconnected service pillars: DP·01 Global Sourcing & Procurement; DP·02 Machinery, Engineering & Technical Support (covering production line sourcing, inspection, and commissioning for Oral Solid Dosage and Small Volume Parenterals); DP·03 Project Management & Facility Development (including segregated GMP containment blocks); DP·04 Formulation & Product Development (with BA/BE study coordination through CROs in approved jurisdictions); DP·05 Technical Manpower & Capability Building (recruitment and deployment of audit-experienced professionals, plus training of local teams); and DP·06 Logistics into Central Africa. Together these form a closed loop in which market intelligence from the region feeds formulation development, which drives procurement, which feeds engineered facilities operated by Dosch-deployed technical teams, with logistics closing the physical distance. Dose-wise, the company supports over 500 SKUs across antimalarials, anti-tuberculars, antiretrovirals, anti-infectives, and broader essential medicines.

The business operates an enterprise field-sales motion targeting pharmaceutical manufacturers in Central Africa and global health procurement programs, with quote-based project engagements spanning procurement markups (transaction-fee revenue on multi-origin sourcing), project-based engineering and facility development fees, professional services for technical manpower deployment, and transaction-fee logistics revenue. Dosch is recognized by the Government of India as a Three Star Export House and holds all required pharmaceutical export and import-export licenses. It is a private limited company with no disclosed parent, no disclosed institutional investors, and no management team information available in the public source material.

Short descriptiontext

Mumbai-based B2B pharmaceutical services platform that enables pharmaceutical manufacturing in Central Africa through integrated multi-origin sourcing from India, China, and Europe, WHO Prequalification-standard vendor qualification, engineering and facility development, technical manpower deployment, and door-to-plant logistics at over 1,000 container shipments annually.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical procurement, pharmaceutical manufacturing enablement, WHO prequalification sourcing, GMP facility development, pharma logistics services
Industry3 codes
PRIMARYHLAIAJAF
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Manufacturing Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Procurement and Sourcing Services
TypeTransaction Fee
Description

Multi-origin procurement of APIs, excipients, packaging materials, and finished goods across India, China, and Europe, qualified to WHO PQ standards. Revenue likely generated through markup on procurement and logistics services.

dosch.com
2Engineering and Technical Services
TypeProfessional Services
Description

Machinery sourcing, facility development, production line commissioning, and ongoing technical support. Typically project-based engagements for GMP facility development and equipment procurement.

dosch.com
3Technical Manpower Deployment
TypeProfessional Services
Description

Recruitment, deployment, and management of pharmaceutical professionals including plant managers, QA/QC specialists, and regulatory affairs personnel.

dosch.com
4Logistics Services
TypeTransaction Fee
Description

Air and sea freight coordination, customs documentation, regulatory compliance, and door-to-plant delivery services into Central Africa.

dosch.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Dosch Pharmaceuticals operates as an integrated pharmaceutical manufacturing enablement platform, serving as the global procurement, engineering, and technical arm of pharmaceutical manufacturers in Central Africa. The company sources APIs, excipients, packaging, and finished goods from India, China, and Europe qualified to WHO Prequalification standards, commissions Oral Solid Dosage and Small Volume Parenteral production lines, develops formulations for regional conditions, deploys pharmaceutical professionals with USFDA/EU/WHO audit experience, and delivers door-to-plant logistics across the Central Africa corridor.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 30+ years of uninterrupted operation in Central Africa corridor
+3 more records
Product overview1 text field

Dosch Pharmaceuticals operates as an integrated pharmaceutical manufacturing enablement platform offering six interconnected service capabilities. The core offering includes Global Sourcing & Procurement (DP·01) for APIs, excipients and finished goods; Machinery, Engineering & Technical Support (DP·02) for production line commissioning; Project Management & Facility Development (DP·03) for GMP facilities; Formulation & Product Development (DP·04) for regional market adaptation; Technical Manpower & Capability Building (DP·05) for skilled personnel deployment; and Logistics into Central Africa (DP·06) for door-to-plant delivery. These six disciplines form a closed loop where development drives sourcing, sourcing feeds engineered facilities, their people operate them, and logistics closes the distance.

Product and service1 record
1DP·01 - Global Sourcing & Procurement
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Asia's largest pharmaceutical distribution services group operating across 13+ Asian markets. A broad incumbent with overlapping pharma distribution and regulatory documentation capabilities, though focused on Asia rather than Africa.

2Imperial Health Sciences
TypeDirect peer
Description

South African pharmaceutical distribution and supply chain company serving sub-Saharan African markets with warehousing, distribution, and supply chain services. Comparable regional pharma logistics capabilities for the African continent.

TypeOthers
Description

Healthcare access consultancy and supply chain solutions provider focused on improving access to medicines in emerging markets. Thematically adjacent — comparable in global health access mission and emerging-market pharma expertise, but consultancy-led rather than operations-led.

TypeBroad incumbent
Description

Global pharmaceutical distribution and solutions company serving manufacturers, pharmacies, and healthcare providers worldwide. Comparable in pharmaceutical sourcing, distribution, and consulting services to manufacturers, at much larger scale.

TypeBroad incumbent
Description

Global generics and specialty pharmaceutical company with significant presence in global health, supplying ARVs and essential medicines to low-income countries. Comparable in global health product portfolio but operates as a manufacturer rather than intermediary.

6IDA Foundation
TypeDirect peer
Description

Dutch non-profit pharmaceutical supplier supplying essential medicines to low- and middle-income countries via WHO PQ-qualified sourcing. Shares the global health procurement and WHO PQ documentation discipline that defines Dosch's regulatory moat.

TypeRegional player
Description

Nigerian pharmaceutical manufacturer producing essential medicines for West African markets with WHO PQ-aligned operations. Comparable in regional African pharmaceutical manufacturing focus, though operating in a different African sub-region.

TypeDirect peer
Description

Danish pharmaceutical supplier specializing in global health procurement and distribution to developing countries, with WHO PQ-aligned product portfolios. Closest analogue to Dosch's procurement-plus-logistics model into Africa.

TypeEmerging player
Description

Indian pharmaceutical manufacturer with strong Africa-focused generics portfolio and WHO PQ-approved products. Comparable therapeutic and geographic focus, though Strides is a product manufacturer rather than a procurement/services intermediary.

10McKesson
TypeBroad incumbent
Description

One of the world's largest pharmaceutical wholesalers and distributors, with global supply chain infrastructure and pharmaceutical sourcing capabilities. Comparable as a broad pharma distribution incumbent, though primarily serving North America and Europe.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dosch Pharmaceuticals

Pharmaceutical Manufacturing Servicesdosch.com

Mumbai-based B2B pharmaceutical services platform that enables pharmaceutical manufacturing in Central Africa through integrated multi-origin sourcing from India, China, and Europe, WHO Prequalification-standard vendor qualification, engineering and facility development, technical manpower deployment, and door-to-plant logistics at over 1,000 container shipments annually.

What Dosch Pharmaceuticals does

Dosch Pharmaceuticals Pvt. Ltd. is a Mumbai-based, privately held B2B pharmaceutical services company that operates as an integrated enablement platform for pharmaceutical manufacturers in Central Africa. Established approximately three decades ago, the company qualifies and sources APIs, excipients, packaging materials, and finished goods from India, China, and Europe to WHO Prequalification standards, then delivers them via air and sea freight into the Central African corridor at a rate of more than 1,000 container shipments annually, completing the route with door-to-plant final-mile logistics.

The company's offering is structured around six interconnected service pillars: DP·01 Global Sourcing & Procurement; DP·02 Machinery, Engineering & Technical Support (covering production line sourcing, inspection, and commissioning for Oral Solid Dosage and Small Volume Parenterals); DP·03 Project Management & Facility Development (including segregated GMP containment blocks); DP·04 Formulation & Product Development (with BA/BE study coordination through CROs in approved jurisdictions); DP·05 Technical Manpower & Capability Building (recruitment and deployment of audit-experienced professionals, plus training of local teams); and DP·06 Logistics into Central Africa. Together these form a closed loop in which market intelligence from the region feeds formulation development, which drives procurement, which feeds engineered facilities operated by Dosch-deployed technical teams, with logistics closing the physical distance. Dose-wise, the company supports over 500 SKUs across antimalarials, anti-tuberculars, antiretrovirals, anti-infectives, and broader essential medicines.

The business operates an enterprise field-sales motion targeting pharmaceutical manufacturers in Central Africa and global health procurement programs, with quote-based project engagements spanning procurement markups (transaction-fee revenue on multi-origin sourcing), project-based engineering and facility development fees, professional services for technical manpower deployment, and transaction-fee logistics revenue. Dosch is recognized by the Government of India as a Three Star Export House and holds all required pharmaceutical export and import-export licenses. It is a private limited company with no disclosed parent, no disclosed institutional investors, and no management team information available in the public source material.

Dosch Pharmaceuticals firmographics

Firmographics
Name
Dosch Pharmaceuticals
Legal name
Dosch Pharmaceuticals Pvt. Ltd.
Website
https://dosch.com
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
51–100 employees
Short description
Mumbai-based B2B pharmaceutical services platform that enables pharmaceutical manufacturing in Central Africa through integrated multi-origin sourcing from India, China, and Europe, WHO Prequalification-standard vendor qualification, engineering and facility development, technical manpower deployment, and door-to-plant logistics at over 1,000 container shipments annually.
Ownership category
akta.pro rank

Dosch Pharmaceuticals industry classification

Industry
Product category
Pharmaceutical Manufacturing Services
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAF
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Pharmaceutical procurement
  • Pharmaceutical manufacturing enablement
  • WHO prequalification sourcing
  • GMP facility development
  • Pharma logistics services

Where Dosch Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Dosch Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Procurement and Sourcing Services: Multi-origin procurement of APIs, excipients, packaging materials, and finished goods across India, China, and Europe, qualified to WHO PQ standards. Revenue likely generated through markup on procurement and logistics services.
  2. Engineering and Technical Services: Machinery sourcing, facility development, production line commissioning, and ongoing technical support. Typically project-based engagements for GMP facility development and equipment procurement.
  3. Technical Manpower Deployment: Recruitment, deployment, and management of pharmaceutical professionals including plant managers, QA/QC specialists, and regulatory affairs personnel.
  4. Logistics Services: Air and sea freight coordination, customs documentation, regulatory compliance, and door-to-plant delivery services into Central Africa.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Dosch Pharmaceuticals product offering

Product offering

Core offering

Dosch Pharmaceuticals operates as an integrated pharmaceutical manufacturing enablement platform, serving as the global procurement, engineering, and technical arm of pharmaceutical manufacturers in Central Africa. The company sources APIs, excipients, packaging, and finished goods from India, China, and Europe qualified to WHO Prequalification standards, commissions Oral Solid Dosage and Small Volume Parenteral production lines, develops formulations for regional conditions, deploys pharmaceutical professionals with USFDA/EU/WHO audit experience, and delivers door-to-plant logistics across the Central Africa corridor.

Product overview

Dosch Pharmaceuticals operates as an integrated pharmaceutical manufacturing enablement platform offering six interconnected service capabilities. The core offering includes Global Sourcing & Procurement (DP·01) for APIs, excipients and finished goods; Machinery, Engineering & Technical Support (DP·02) for production line commissioning; Project Management & Facility Development (DP·03) for GMP facilities; Formulation & Product Development (DP·04) for regional market adaptation; Technical Manpower & Capability Building (DP·05) for skilled personnel deployment; and Logistics into Central Africa (DP·06) for door-to-plant delivery. These six disciplines form a closed loop where development drives sourcing, sourcing feeds engineered facilities, their people operate them, and logistics closes the distance.

Differentiator

Problem solved

Functional benefit

Products and services

  • DP·01 - Global Sourcing & Procurement

Quantifiable outcome

  • 30+ years of uninterrupted operation in Central Africa corridor
  • +3 more outcomes

Companies that use Dosch Pharmaceuticals

Customer profile

Segments2 records

Ideal customer profiles2 records

Dosch Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Dosch Pharmaceuticals partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Dosch Pharmaceuticals competitors and assessment

Company assessment

Broad incumbents

  • Zuellig Pharma: Asia's largest pharmaceutical distribution services group operating across 13+ Asian markets. A broad incumbent with overlapping pharma distribution and regulatory documentation capabilities, though focused on Asia rather than Africa.
  • Cencora (AmerisourceBergen): Global pharmaceutical distribution and solutions company serving manufacturers, pharmacies, and healthcare providers worldwide. Comparable in pharmaceutical sourcing, distribution, and consulting services to manufacturers, at much larger scale.
  • Viatris: Global generics and specialty pharmaceutical company with significant presence in global health, supplying ARVs and essential medicines to low-income countries. Comparable in global health product portfolio but operates as a manufacturer rather than intermediary.
  • McKesson: One of the world's largest pharmaceutical wholesalers and distributors, with global supply chain infrastructure and pharmaceutical sourcing capabilities. Comparable as a broad pharma distribution incumbent, though primarily serving North America and Europe.

Direct peers

  • Imperial Health Sciences: South African pharmaceutical distribution and supply chain company serving sub-Saharan African markets with warehousing, distribution, and supply chain services. Comparable regional pharma logistics capabilities for the African continent.
  • IDA Foundation: Dutch non-profit pharmaceutical supplier supplying essential medicines to low- and middle-income countries via WHO PQ-qualified sourcing. Shares the global health procurement and WHO PQ documentation discipline that defines Dosch's regulatory moat.
  • Missionpharma: Danish pharmaceutical supplier specializing in global health procurement and distribution to developing countries, with WHO PQ-aligned product portfolios. Closest analogue to Dosch's procurement-plus-logistics model into Africa.

Others

  • Axios International: Healthcare access consultancy and supply chain solutions provider focused on improving access to medicines in emerging markets. Thematically adjacent — comparable in global health access mission and emerging-market pharma expertise, but consultancy-led rather than operations-led.

Regional players

  • Swipha: Nigerian pharmaceutical manufacturer producing essential medicines for West African markets with WHO PQ-aligned operations. Comparable in regional African pharmaceutical manufacturing focus, though operating in a different African sub-region.

Emerging players

  • Strides Pharma Science: Indian pharmaceutical manufacturer with strong Africa-focused generics portfolio and WHO PQ-approved products. Comparable therapeutic and geographic focus, though Strides is a product manufacturer rather than a procurement/services intermediary.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

Dosch Pharmaceuticals compliance and trust

Trust signal

Compliance3 records

Dosch Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dosch Pharmaceuticals leadership team

Management profile

Number of profiles

Dosch Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dosch Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dosch Pharmaceuticals

What does Dosch Pharmaceuticals do?

Dosch Pharmaceuticals operates as an integrated pharmaceutical manufacturing enablement platform, serving as the global procurement, engineering, and technical arm of pharmaceutical manufacturers in Central Africa. The company sources APIs, excipients, packaging, and finished goods from India, China, and Europe qualified to WHO Prequalification standards, commissions Oral Solid Dosage and Small Volume Parenteral production lines, develops formulations for regional conditions, deploys pharmaceutical professionals with USFDA/EU/WHO audit experience, and delivers door-to-plant logistics across the Central Africa corridor.

Is Dosch Pharmaceuticals a public or private company?

Dosch Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Dosch Pharmaceuticals founded?

Dosch Pharmaceuticals was founded in 1990. It employs 51 to 100 people.

Where is Dosch Pharmaceuticals based?

Dosch Pharmaceuticals is headquartered in Mumbai, India, in the Asia region.

How does Dosch Pharmaceuticals make money?

Four revenue lines are on record. Procurement and Sourcing Services are the primary driver. The others are engineering and Technical Services, technical Manpower Deployment and logistics Services.

Who are Dosch Pharmaceuticals's main competitors?

Broad incumbents on record are Zuellig Pharma, Cencora (AmerisourceBergen), Viatris and McKesson. Direct peers are Imperial Health Sciences, IDA Foundation and Missionpharma. Axios International is listed as an others. Swipha is listed as a regional player. Strides Pharma Science is listed as an emerging player.

Does Dosch Pharmaceuticals have an API?

No public API is recorded for Dosch Pharmaceuticals.

What industry is Dosch Pharmaceuticals in?

Dosch Pharmaceuticals's product category is Pharmaceutical Manufacturing Services. Its primary akta.pro industry code is HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor), with a secondary code of HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales